Historical Valuation
Incyte Corp (INCY) is now in the Fair zone, suggesting that its current forward PE ratio of 13.67 is considered Fairly compared with the five-year average of 19.07. The fair price of Incyte Corp (INCY) is between 91.80 to 186.40 according to relative valuation methord.
Relative Value
Fair Zone
91.80-186.40
Current Price：105.92
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Incyte Corp (INCY) has a current Price-to-Book (P/B) ratio of 4.28. Compared to its 3-year average P/B ratio of 3.45 , the current P/B ratio is approximately 23.79% higher. Relative to its 5-year average P/B ratio of 4.11, the current P/B ratio is about 4.02% higher. Incyte Corp (INCY) has a Forward Free Cash Flow (FCF) yield of approximately 6.01%. Compared to its 3-year average FCF yield of 3.58%, the current FCF yield is approximately 67.82% lower. Relative to its 5-year average FCF yield of 3.35% , the current FCF yield is about 79.67% lower.
P/B
Median3y
3.45
Median5y
4.11
FCF Yield
Median3y
3.58
Median5y
3.35
Competitors Valuation Multiple
AI Analysis for INCY
The average P/S ratio for INCY competitors is 36.73, providing a benchmark for relative valuation. Incyte Corp Corp (INCY.O) exhibits a P/S ratio of 3.70, which is -89.94% above the industry average. Given its robust revenue growth of 20.05%, this premium appears sustainable.
Performance Decomposition
AI Analysis for INCY
1Y
3Y
5Y
Market capitalization of INCY increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of INCY in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is INCY currently overvalued or undervalued?
Incyte Corp (INCY) is now in the Fair zone, suggesting that its current forward PE ratio of 13.67 is considered Fairly compared with the five-year average of 19.07. The fair price of Incyte Corp (INCY) is between 91.80 to 186.40 according to relative valuation methord.
What is Incyte Corp (INCY) fair value?
INCY's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Incyte Corp (INCY) is between 91.80 to 186.40 according to relative valuation methord.
How does INCY's valuation metrics compare to the industry average?
The average P/S ratio for INCY's competitors is 36.73, providing a benchmark for relative valuation. Incyte Corp Corp (INCY) exhibits a P/S ratio of 3.70, which is -89.94% above the industry average. Given its robust revenue growth of 20.05%, this premium appears sustainable.
What is the current P/B ratio for Incyte Corp (INCY) as of Jan 09 2026?
As of Jan 09 2026, Incyte Corp (INCY) has a P/B ratio of 4.28. This indicates that the market values INCY at 4.28 times its book value.
What is the current FCF Yield for Incyte Corp (INCY) as of Jan 09 2026?
As of Jan 09 2026, Incyte Corp (INCY) has a FCF Yield of 6.01%. This means that for every dollar of Incyte Corp’s market capitalization, the company generates 6.01 cents in free cash flow.
What is the current Forward P/E ratio for Incyte Corp (INCY) as of Jan 09 2026?
As of Jan 09 2026, Incyte Corp (INCY) has a Forward P/E ratio of 13.67. This means the market is willing to pay $13.67 for every dollar of Incyte Corp’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Incyte Corp (INCY) as of Jan 09 2026?
As of Jan 09 2026, Incyte Corp (INCY) has a Forward P/S ratio of 3.70. This means the market is valuing INCY at $3.70 for every dollar of expected revenue over the next 12 months.